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Abstract
A loss of physical functioning (i.e., a low physical capacity and/or a low physical activity) is a common feature in patients 
with chronic obstructive pulmonary disease (COPD). To date, the primary care physiotherapy and specialized pulmonary 
rehabilitation are clearly underused, and limited to patients with a moderate to very severe degree of airflow limitation 
(GOLD stage 2 or higher). However, improved referral rates are a necessity to lower the burden for patients with COPD 
and for society. Therefore, a multidisciplinary group of healthcare professionals and scientists proposes a new model for 
referral of patients with COPD to the right type of exercise-based care, irrespective of the degree of airflow limitation. 
Indeed, disease instability (recent hospitalization, yes/no), the burden of disease (no/low, mild/moderate or high), physical 
capacity (low or preserved) and physical activity (low or preserved) need to be used to allocate patients to one of the six 
distinct patient profiles. Patients with profile 1 or 2 will not be referred for physiotherapy; patients with profiles 3–5 will be 
referred for primary care physiotherapy; and patients with profile 6 will be referred for screening for specialized pulmonary 
rehabilitation. The proposed Dutch model has the intention to get the right patient with COPD allocated to the right type of 
exercise-based care and at the right moment.
1 Introduction
Despite medical treatment by the general practitioner, an 
impaired physical, emotional and/or social functioning has 
been frequently reported in Dutch primary care patients 
with chronic obstructive pulmonary disease (COPD) [1–3]. 
These abnormalities can co-occur in different combinations, 
regardless of the degree of airflow limitation. Similar find-
ings have been reported in patients with COPD who were 
under the care of Dutch pulmonologists [4, 5].
A loss of physical functioning (i.e., a low physical capac-
ity and/or a low physical activity) is a common feature in 
patients with COPD [3, 6, 7]. Exercise-based interventions 
(combined with self-management education) and/or physical 
activity coaching programs can result in clinically relevant 
improvements in daily symptom burden, physical capacity, 
physical activity and health status compared to usual care 
in patients with COPD [8]. An interdisciplinary comprehen-
sive pulmonary rehabilitation (PR) program is defined as 
‘a comprehensive intervention based on a thorough patient 
assessment followed by patient-tailored therapies, which 
include, but are not limited to, exercise training, education, 
and behavior change, designed to improve the physical and 
psychological condition of people with chronic respiratory 
disease and to promote the long-term adherence of health-
enhancing behaviors’ [9]. Such programs have shown to 
also improve the performance of activities of daily living, 
to increase self-efficacy, and to lower the degree of care 
dependency and healthcare utilization [5, 10–14] in COPD 
patients with a combination of physical, emotional and/or 
social treatable traits. Even though safety and efficacy of 
these interventions are clear, referral by physicians remains 
poor [15]. * Martijn A. Spruit  martijnspruit@ciro-horn.nl
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2  Current Clinical Practice
Current guidelines state that the degree of clinical complexity 
should determine the types of (pharmacological and non-phar-
macological) interventions provided, ranging from healthy 
lifestyle advise combined with recommended drug therapy 
[16, 17], up to a comprehensive, inpatient, interdisciplinary 
PR program for patients with multiple physical, emotional 
and/or social treatable traits at the time of referral [10, 18].
Since January 2019, patients with COPD in the Nether-
lands are entitled to reimbursement of the costs of physi-
otherapy (or exercise therapy Cesar/Mensendieck) provided 
in the primary care setting via the basic national healthcare 
insurance [19]. Indeed, the National Healthcare Institute 
advised the Dutch Minister of Health, Welfare and Sport that 
patients with moderate to very severe COPD (FEV1 < 80% 
predicted) are eligible to receive a maximum number of 
reimbursed physiotherapy sessions in the first 12 months of 
treatment and during the enduring maintenance phase. How-
ever, GOLD C/D patients who suffer from a new exacerba-
tion during/after treatment are not entitled to reimbursement 
of the costs of extra physiotherapy sessions. Moreover, the 
maximum number of sessions is solely based on the GOLD 
ABCD classification at the time of referral, and excludes 
GOLD 1 patients (Table 1). However, a subgroup of GOLD 
1 patients can suffer from an impaired physical functioning 
[3], which justifies early referral to exercise-related care, 
such as physiotherapy [20]. Also respiratory symptom bur-
den and exacerbation history (the two attributes required 
to classify patients into GOLD ABCD) have not been vali-
dated to identify the right candidates for the right type of 
exercise-based care in patients with COPD. Consequently, 
highly-symptomatic GOLD B patients are currently entitled 
to a lower maximum number of reimbursed physiotherapy 
sessions than the no/low-symptomatic GOLD C patients 
(Table 1). Moreover, potentially important targets for physi-
otherapy, such as exercise intolerance and physical inactiv-
ity, are ignored in current Dutch referral rules, but vary to 
a great extent in the different GOLD groups and cannot be 
derived truthfully from the total scores of the Clinical COPD 
Questionnaire (CCQ) or COPD Assessment Test (CAT), the 
questionnaires that are used to qualify patients as GOLD 
A/C or B/D [21]. Finally, a large variation in treatable traits 
is present within specific GOLD groups [22]. This neces-
sitates additional assessment of the physical, emotional and 
social status of patients with COPD to truly understand the 
disease burden, and to put together a patient-tailored treat-
ment program, including exercise-based care.
3  The 2020 Dutch Model
An ad hoc Task Force, including experts in the field of 
physiotherapy, exercise therapy (Cesar and Mensendieck), 
rehabilitation sciences, respiratory medicine, general medi-
cine, elderly care medicine and patient representatives, put 
together an alternative practice- and experience-based pro-
posal (Fig. 1). This newly proposed flowchart includes an ini-
tial patient profiling at the office of the general practitioner or 
pulmonologist, using a short and simple questionnaire (CCQ 
or CAT, which both go beyond respiratory symptoms [23, 
24]) to determine the degree of disease burden [24, 25]. The 
modified Medical Research Council (mMRC) dyspnoea scale 
is not proposed as initial screening tool, as its focus is too 
limited to truthfully capture the multidimensional symptoms/
limitations of patients with COPD [23, 27].
3.1  No‑to‑Low Disease Burden
Patients with no-to-low self-reported disease burden 
(CCQ < 1.0 point; CAT < 10 points [26]) will most probably 
Table 1  The number of reimbursed physiotherapy sessions in pri-
mary care for patients with COPD (since January 2019)














Number of session in the 
1st year
5 27 70 70
Number of sessions in the 
enduring maintenance 
phase
0 3 52 52
Key Points 
To date, use of primary care physiotherapy or special-
ized pulmonary rehabilitation programs is very limited 
in patients with COPD (5.0 and 0.2%, respectively), 
while a larger proportion of these patients clearly qualify 
for this type of care.
The current organization of Dutch healthcare needs to 
make a transition towards an adequate referral of patients 
with COPD to the different types of exercise-based care, 
including a healthy lifestyle advise, physiotherapy and/or 
specialized pulmonary rehabilitation programs.
Disease stability, disease burden, physical capacity and 
physical activity are important traits to get the right 
patient allocated to the right type of exercise-related care 
and at the right moment, irrespective of the degree of 
airflow limitation.
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have no clearly defined exercise-related treatment goal for 
which they need advice/supervision from a healthcare pro-
fessional. Therefore, the general practitioner will provide 
these patients with healthy lifestyle advice, including an 
advice to remain regularly physically active [17]. However, 
there will be no referral for additional physiotherapy or PR 
(Fig. 1; patient profile 1). Once yearly or if a physician-
treated exacerbation occurs earlier, the patient profiling re-
starts from the top of Fig. 1.
3.2  Mild‑to‑Moderate Disease Burden
Patients with a mild-to-moderate self-reported burden of 
disease (CCQ 1.0–1.8 points; CAT 10–17 points [24]) will 
be referred to a physiotherapist (or exercise therapist Cesar/
Mensendieck; in the primary or secondary care setting, 
with sufficient knowledge and skills in exercise-based care 
of patients with chronic lung diseases) to assess physical 
functioning during two screening visits. During the initial 
screening visit, patients will undergo an intake by the physi-
otherapist and a field-based exercise test, such as the 6-min 
walk test (6MWT) [28, 29]. Moreover, the patients will also 
receive a step counter/accelerometer, which will be returned 
at the second screening visit, 1 week later. During this sec-
ond screening visit physical activity is evaluated and the 
6MWT is repeated [30]. Patients with a rather preserved 
physical capacity (> 70% predicted value [3]) and physical 
activity (> 5000 steps per day [3]) will receive healthy life-
style advice, but no additional professional allied healthcare 
(Fig. 1; patient profile 2). Once yearly or if a physician-
treated exacerbation occurs earlier, the profiling re-starts 
from the top of Fig. 1. Patients with profiles 1 or 2 seem to 
Fig. 1  Flowchart for exercise-based care for patients with COPD. 
CCQ Clinical COPD Questionnaire, CAT COPD Assessment Test, 
% % predicted value, st/d steps per day. *During hospital admission 
patients with COPD should be offered exercise-based physiotherapy 
in addition to regular respiratory physiotherapy [58]. ‡Frail patients 
with COPD in the palliative phase of the disease, those who are on 
the waiting list for lung transplantation, those who are on long-term 
oxygen therapy, those who are on non-invasive ventilation, and/
or those with comorbidities which seriously affect physical capac-
ity/activity. †Patients who are willing to pay out of pocket. Gray 
area: two 1-h pre-treatment screening sessions to do an intake, and 
to assess physical capacity and physical activity (as described in the 
text). Patients who are do not enter a pulmonary rehabilitation pro-
gram after the screening, will be referred for exercise-based primary 
care, according to the described profiling 2–5
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be good candidates to participate in regular sports/walking 
activities as organized for elderly in the local communities, 
which stimulates regular walking in patients with COPD and 
their loved ones [31].
For patients with a mild-to-moderate self-reported dis-
ease burden, accompanied by an impaired physical func-
tion [low physical capacity (≤ 70% predicted value) and/or 
low physical activity (≤ 5000 steps per day)], intervention 
will start in the primary care physiotherapy setting (Fig. 1; 
patient profiles 3–5). In profile 3, the treatment will focus 
on physical activity coaching to increase the daily physical 
activity [32]; in profile 4, the treatment will focus on exer-
cise training to increase the physical capacity [33, 34]; and 
in profile 5 it will be a combination thereof. As profile 5 
patients have to increase their physical capacity and physical 
activity, it seems fair that they are entitled to the reimburse-
ment of the costs of more physiotherapy sessions provided in 
the primary care setting compared to profile 3 or 4 patients 
(Table 2). The current reimbursement of primary care physi-
otherapy sessions for the GOLD D patients (Table 1) will 
suffice for the newly proposed model. In contrast, the num-
ber of reimbursed physiotherapy sessions for patients with 
COPD GOLD B needs to increase to enable the proposed 
model. It is hard to understand why GOLD D patients are 
entitled to a higher number of primary care physiotherapy 
sessions than GOLD B patients. Indeed, a secondary analy-
sis of the data of Koolen et al. [3] shows no differences 
in physical capacity and physical activity between GOLD 
B or D patients after stratification for patient profiles 2 to 
5 (Fig. 2). Obviously, respiratory physiotherapy, including 
mucus evacuation techniques, needs to be offered if indi-
cated [35].
Understandably, the aims of the individual patient and the 
success of treatment should determine the total number of 
physiotherapy sessions. If the treatment in the primary care 
setting fails, referral for a thorough assessment of underlying 
pathophysiological mechanisms as well as for screening for 
interdisciplinary PR should be discussed with the patient 
and referral physician. Possible unknown, common medi-
cal comorbidities [36] may cause this failure, and should be 
actively screened for [37]. Moreover, the lack of motivation 
and the lack of social support, may also, at least partially, 
explain failure of therapy [38].
If the physiotherapy is successful (i.e., patient’s goals 
have been achieved), participation in regular sports/walk-
ing activities as organized for elderly in the local communi-
ties [17] seems feasible and should be recommended in the 
maintenance phase. Follow up of the physical capacity and 
physical activity of these patients by the physiotherapist over 
time (for example, two evaluative sessions every 6 months) 
seems sensible and should be considered for reimburse-
ment. If the physical capacity has declined > 45 m on the 
6-min walk test and/or the physical activity is > 1500 steps/
day lower compared to previous assessment (i.e., a decline 
which exceeds 1.5 times the known MCID), a re-start of 
the physiotherapy should be deliberated in consultation with 
the treating physician. If a physician-treated exacerbation 
occurs during follow up, the profiling re-starts from the top 
of Fig. 1.
3.3  High Disease Burden
Patients with COPD with a high self-reported disease 
burden (CCQ ≥ 1.9 points; CAT ≥ 18 points [24]), will be 
referred for a screening for PR. This is also proposed for 
patients who have recently been admitted to the hospital for 
an exacerbation, the so-called lung attack (Fig. 1; patient 
profile 6), as this is associated with significant deterioration 
Table 2  The number of reimbursed physiotherapy sessions in primary care for patients with profiles 3, 4 or 5 according to the proposed 2020 
Dutch model
One session = 30 min
a We propose that GOLD stage 1 patients are also eligible for exercise-related care, as described Fig. 1; after a physician-treated COPD exacerba-
tion, the profiling re-starts from the top of Fig. 1 and the number of sessions start from zero. Obviously, patients need to be encouraged to con-
tinue physical activity and/or training in and/or near their home-environment when the number of supervised physiotherapy sessions is decreas-
ing
Patient profile  3a Patient profile  4a Patient profile  5a
Pre-treatment screening sessions 2 days, 2 consecutive sessions/day 2 days, 2 consecutive sessions/day 2 days, 2 consecutive sessions/day




12 weeks, 3x/week 12 weeks, 3x/week
Intermediate evaluation sessions 
(12 weeks after start of therapy)
2 days, 2 consecutive sessions/day 2 days, 2 consecutive sessions/day 2 days, 2 consecutive sessions/day




14 weeks, 1x/week 14 weeks, 1x/week
18 weeks, 1x/2 weeks, 1x/4 weeks
Post-treatment evaluation session 2 days, 2 consecutive sessions/day 2 days, 2 consecutive sessions/day 2 days, 2 consecutive sessions/day
Total number of sessions 42 62 74
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of physical capacity, physical activity, and health status 
[39, 40]. Whether a patient should undergo a multidiscipli-
nary PR program in secondary care, or a comprehensive, 
interdisciplinary, PR program in a Center of Expertise for 
Patients with Complex Chronic Lung Disease (tertiary care), 
depends on the degree of clinical complexity [18]. The clini-
cal complexity may be operationalized by determining the 
number of treatable traits that is the number of potential 
targets for different rehabilitation ingredients [41, 42]. Obvi-
ously, also the interactions between treatable traits can also 
add to the clinical complexity, which is more challenging 
to operationalize [43]. As the degree of clinical complexity 
cannot be derived confidently from the degree of lung func-
tion impairment [4], a thorough pre-PR assessment has to 
determine the correct treatment allocation (Table 3). Patients 
with ≤ 2 treatable traits will be referred for an outpatient PR 
program in secondary care (outpatient, 8–12 weeks, three 
sessions per week, which will include physiotherapy and 
one or two other health disciplines, like health promotion 
and dietician; Fig. 1; patient profile 6A), while the remain-
ing patients are appropriate candidates for a comprehensive, 
interdisciplinary PR program in a Centre of Expertise for 
Patients with Complex Chronic Lung Disease (specialized 
care; a minimum of 8 weeks, 3–5 PR days per week, with 
the possibility for inpatient stay), which will include physi-
otherapy, occupational therapy, dietary counseling, nutri-
tional modulation, psychology, health promotion, enhanced 
art therapy, counseling by social work and respiratory nurse, 
respiratory medicine, and treatment of comorbidities (cardi-
ology and internal medicine [18]; Fig. 1; patient profile 6B). 
Obviously, the inclusion criteria for treatment in a Centre of 
Expertise for Patients with Complex Chronic Lung Disease 
may change over time due to new insights. Indeed, cognitive 
functioning [44] and health literacy skills should be contem-
plated [45].
After completion of the PR program, including a struc-
tured outcome evaluation, the patients should be referred 
for at least once-weekly physiotherapy in the primary care 
setting to maintain the benefits in physical functioning and 
self-efficacy during the maintenance phase. To the future, 
E-health/M-health may also be put in place to coach and 
monitor patients during the enduring maintenance phase, 
which may stabilize physical capacity/activity levels, 
reduce in-person visits and may contribute to a better dis-
ease management [46, 47]. Robust evidence, however, is 
currently lacking [48].
4  Discussion
In The Netherlands, about 600,000 people are diagnosed 
with COPD [19]. As the burden to the patients as well as 
to society is clearly present [49], the current organization 
of Dutch healthcare needs to make a transition towards an 
adequate referral of these patients to the different types of 
exercise-based care, including a healthy lifestyle advise, 
physiotherapy and/or PR. We propose the abovementioned 
patient profiling as a basis for this allocation. This type 
of matched care starts in the physician’s office or during 
an exacerbation-related hospital admission. Therefore, 
systematically quantifying the degree of disease burden 




















































































































































Fig. 2  a Physical capacity in patients with COPD after stratifica-
tion for patient profile (2–5) and GOLD group (B or D). b Physical 
activity in patients with COPD after stratification for patient profile 
(2–5) and GOLD group (B or D). 6MWD 6 min walk distance, GOLD 
Global initiative for chronic Obstructive Lung Disease.  Data are 
derived from a secondary analysis of the data of Koolen et al. [3]
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considered as a future key process indicator. Clearly, large 
differences exist between countries concerning organiza-
tional aspects and content of exercise-based care programs 
for patients with COPD [50]. These local circumstances, 
as well as patient’s preference, may affect the proposed 
flowchart.
To date, use of primary care physiotherapy or PR is esti-
mated to be very limited in The Netherlands (5.0 and 0.2%, 
respectively), while a larger proportion of the patients with 
COPD clearly qualify for this type of care [3]. So, improved 
referral rates are a necessity to lower the disease burden 
for patients and society. The proposed Dutch model has the 
intention to get the right patient allocated to the right type 
of exercise-related care and at the right moment, irrespec-
tive of the degree of airflow limitation. This will also avoid 
unnecessary exercise-related care expenses for patients with 
no-to-low disease burden and a preserved physical capacity/
activity.
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